Find → Understand → Decide
ADX71149
Discovery priority: LOW · POSSIBLE / INVESTIGATE
Discovery priority ≠ investment recommendation. These are observation labels, not verified canonical products. Buyer qualification: UNKNOWN.
Why investigate?
Why stranded (event context): inadequate public evidence
Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established
Company/trial failed before biology? UNKNOWN
Biology implicated: UNCLEAR · Failure context: UNKNOWN
MODEL INFERENCE · LOW confidence. Explicit asset-linked program event or documented experimental trial arm, stop scope, dated recency and biological cautions; no publication count or buyer-gate input.
Current control: UNKNOWN · Restart: UNKNOWN · Development reuse: UNKNOWN
Next diligence: Confirm present program status and exact product identity, then trace scoped rights/data/CMC and review arm-level human outcomes.
Existing buyer gates
Human Signal: UNKNOWN
Cheap Truth: UNKNOWN
Clean Rights: UNKNOWN
Market Pull: UNKNOWN
No event or publication count supplies missing gate evidence. Existing reviewed opportunities remain in their original records.
Evidence timeline
2025-04-17 · program:reported partnership rights return
Issuer release date reported by search result; subsequent direct fetch timed out
SOURCE TEXT · Exact source
has return all development and commercialization rights to ADX71149 (JNJ-40411813) and the partnership between the two companies has been terminated.
Present scoped control, intervening transfers, obligations and availability unverified
Interpretation: inadequate public evidence · MACHINE_REVIEW · MEDIUM
Provenance and retrieval scope
{
"hash": "1c49e9fb0699b117cc35f9b62f23e9cd39a19998a6ec244f2205c439100c8be9",
"hash_scope": "Retained search-result excerpt only, not complete issuer document",
"metadata": {
"complete": false,
"scope": "Cached issuer excerpt; current scoped ownership not verified; direct fetch timeout"
},
"raw_path": "research/obz7_sources/addex_search_excerpt.txt",
"type": "rights",
"url": "https://www.addextherapeutics.com/en/investors/press-releases/addex-regains-rights-phase-2-mglu2-pam-asset-adx71149/"
}Freshness is claim-specific
Fetching an old filing today does not establish current ownership or program status.
clinicaltrials · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
pipeline · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
sec · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
contact · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
patent_assignment · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
rights · PARTIAL · Cached issuer excerpt; current scoped ownership not verified; direct fetch timeout · checked UNKNOWN
Registry observations (0)